• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食改变涉及长双歧杆菌和其他营养物质可延缓慢性肾脏病进展。

Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.

机构信息

Department of Nephrology, Wakayama Medical University, Wakayama, Japan.

Laboratory Animal Research Center, Nara Medical University, Kashihara, Japan.

出版信息

Am J Nephrol. 2018;47(5):325-332. doi: 10.1159/000488947. Epub 2018 May 18.

DOI:10.1159/000488947
PMID:29779028
Abstract

BACKGROUND

Recent studies suggest that prebiotic and/or probiotic treatments ameliorate kidney function in humans and animals by improving the gut environment. However, the gut microbiota and kidney disease interactions remain to be determined. This study investigated whether synbiotics modulate the gut microbiota and ameliorate kidney function using a rat model of chronic kidney disease (CKD). As uremic toxins are associated with CKD-related mineral and bone disorder, the secondary aim was to evaluate the relationship between synbiotics and secondary hyperparathyroidism (SHPT).

METHODS

5/6 nephrectomy (Nx) rats were developed as the CKD model. Sham-operated (sham) rats were used as the control. To investigate the effectiveness of prebiotics (glutamine, dietary fiber, and oligosaccharide) and probiotics (Bifidobacterium longum strain; GFOB diet), rats were randomly assigned to 4 groups: Nx group fed the GFOB diet (n = 10); Nx group fed the control (CON) diet (n = 10); sham group fed the GFOB diet (n = 5); and sham group fed the control diet (n = 5). Blood, feces, and kidney samples were collected and analyzed.

RESULTS

Serum creatinine (Cre) and blood urea nitrogen in the Nx GFOB group were significantly lower than those in the Nx CON group. Serum indoxyl sulfate in the Nx GFOB group was lower than that in the Nx CON group, and significantly correlated with serum Cre. Inorganic phosphorus and intact parathyroid hormone in the Nx GFOB group were significantly lower than those in the Nx CON group.

CONCLUSION

Improving the gut environment using synbiotics ameliorated kidney function and might be a pharmacological treatment for SHPT without any serious adverse events.

摘要

背景

最近的研究表明,通过改善肠道环境,益生元和/或益生菌治疗可以改善人类和动物的肾功能。然而,肠道微生物群与肾脏疾病的相互作用仍有待确定。本研究使用慢性肾脏病(CKD)大鼠模型,研究了合生元是否通过调节肠道微生物群来改善肾功能。由于尿毒症毒素与 CKD 相关的矿物质和骨代谢紊乱有关,因此次要目的是评估合生元与继发性甲状旁腺功能亢进症(SHPT)之间的关系。

方法

5/6 肾切除术(Nx)大鼠被开发为 CKD 模型。假手术(sham)大鼠作为对照。为了研究益生元(谷氨酰胺、膳食纤维和低聚糖)和益生菌(长双歧杆菌菌株;GFOB 饮食)的有效性,将大鼠随机分为 4 组:Nx 组给予 GFOB 饮食(n = 10);Nx 组给予对照(CON)饮食(n = 10);假手术组给予 GFOB 饮食(n = 5);假手术组给予对照饮食(n = 5)。收集和分析血液、粪便和肾脏样本。

结果

Nx GFOB 组的血清肌酐(Cre)和血尿素氮明显低于 Nx CON 组。Nx GFOB 组的血清吲哚硫酸酯低于 Nx CON 组,且与血清 Cre 显著相关。Nx GFOB 组的无机磷和全段甲状旁腺激素明显低于 Nx CON 组。

结论

使用合生元改善肠道环境可改善肾功能,并且可能是一种治疗 SHPT 的药理学方法,而无任何严重不良反应。

相似文献

1
Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.饮食改变涉及长双歧杆菌和其他营养物质可延缓慢性肾脏病进展。
Am J Nephrol. 2018;47(5):325-332. doi: 10.1159/000488947. Epub 2018 May 18.
2
Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.慢性肾脏病中益生元、益生菌和合生菌补充剂的应用:系统评价和荟萃分析。
J Ren Nutr. 2019 May;29(3):209-220. doi: 10.1053/j.jrn.2018.08.008. Epub 2018 Oct 23.
3
Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats.通过益生菌、益生元和合生元作用于肠-脑轴,降低小胶质细胞的激活,可有效恢复肥胖伴胰岛素抵抗大鼠的认知功能。
J Neuroinflammation. 2018 Jan 9;15(1):11. doi: 10.1186/s12974-018-1055-2.
4
Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.乳果糖对腺嘌呤诱导的慢性肾脏病大鼠肾功能和肠道微生物群的影响。
Clin Exp Nephrol. 2019 Jul;23(7):908-919. doi: 10.1007/s10157-019-01727-4. Epub 2019 Mar 20.
5
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.合生元通过改善肠道微生物群缓解肾衰竭(SYNERGY):一项随机试验
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):223-31. doi: 10.2215/CJN.05240515. Epub 2016 Jan 15.
6
Effects of probiotics, prebiotics or synbiotics on jawbone in obese-insulin resistant rats.益生菌、益生元或合生菌对肥胖-胰岛素抵抗大鼠颌骨的影响。
Eur J Nutr. 2019 Oct;58(7):2801-2810. doi: 10.1007/s00394-018-1829-4. Epub 2018 Sep 24.
7
A Renal Clinician's Guide to the Gut Microbiota.肾脏科医生实用指南:肠道微生物群
J Ren Nutr. 2020 Sep;30(5):384-395. doi: 10.1053/j.jrn.2019.11.002. Epub 2020 Jan 9.
8
Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats.肠道乳酸杆菌通过调节大鼠肠道环境来预防肾损伤进展。
Nephrol Dial Transplant. 2016 Mar;31(3):401-12. doi: 10.1093/ndt/gfv353. Epub 2015 Oct 20.
9
Dietary Phosphorus Levels Influence Protein-Derived Uremic Toxin Production in Nephrectomized Male Rats.饮食磷水平影响肾切除雄性大鼠的蛋白源性尿毒症毒素的产生。
Nutrients. 2024 Jun 8;16(12):1807. doi: 10.3390/nu16121807.
10
Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.在 CKD 进展过程中,肠道氨基酸代谢紊乱与肠道微生物失调和宏基因组变化有关。
J Pharm Biomed Anal. 2018 Feb 5;149:425-435. doi: 10.1016/j.jpba.2017.11.040. Epub 2017 Nov 15.

引用本文的文献

1
Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation.针对肠道微生物群进行糖尿病肾病治疗:益生菌、饮食干预和粪便微生物群移植。
Front Endocrinol (Lausanne). 2025 Jun 30;16:1621968. doi: 10.3389/fendo.2025.1621968. eCollection 2025.
2
The association between dietary live microbe intake and risk of chronic kidney disease among US adults: a cross-sectional survey from NHANES (2001-2018).美国成年人饮食中摄入活微生物与慢性肾病风险之间的关联:一项来自美国国家健康与营养检查调查(2001 - 2018年)的横断面研究
Ren Fail. 2025 Dec;47(1):2488236. doi: 10.1080/0886022X.2025.2488236. Epub 2025 Apr 15.
3
Potential effects of probiotics on atherosclerosis.
益生菌对动脉粥样硬化的潜在影响。
Microbiome Res Rep. 2024 Dec 21;4(1):11. doi: 10.20517/mrr.2024.22. eCollection 2025.
4
Lactobacillus johnsonii Generates Cyclo(pro-trp) and Promotes Intestinal Ca Absorption to Alleviate CKD-SHPT.约氏乳杆菌产生环(脯氨酸-色氨酸)并促进肠道钙吸收以减轻慢性肾脏病继发性甲状旁腺功能亢进。
Adv Sci (Weinh). 2025 Apr;12(16):e2414678. doi: 10.1002/advs.202414678. Epub 2025 Jan 31.
5
Indoxyl sulfate induces retinal microvascular injury via COX-2/PGE activation in diabetic retinopathy.硫酸吲哚酚通过 COX-2/PGE 激活诱导糖尿病视网膜病变中的视网膜微血管损伤。
J Transl Med. 2024 Sep 27;22(1):870. doi: 10.1186/s12967-024-05654-1.
6
Lactobacillus acidophilus KBL409 protects against kidney injury via improving mitochondrial function with chronic kidney disease.嗜酸乳杆菌 KBL409 通过改善慢性肾脏病的线粒体功能来预防肾损伤。
Eur J Nutr. 2024 Sep;63(6):2121-2135. doi: 10.1007/s00394-024-03408-9. Epub 2024 May 6.
7
Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease gut microbiota regulation.来自植物和微生物的天然产物:用于慢性肾病肠道微生物群调节的新型疗法
Front Pharmacol. 2023 Jan 17;13:1068613. doi: 10.3389/fphar.2022.1068613. eCollection 2022.
8
Advances in the treatment of secondary and tertiary hyperparathyroidism.继发性和三发性甲状旁腺功能亢进症的治疗进展。
Front Endocrinol (Lausanne). 2022 Dec 6;13:1059828. doi: 10.3389/fendo.2022.1059828. eCollection 2022.
9
Exploring the Relevance between Gut Microbiota-Metabolites Profile and Chronic Kidney Disease with Distinct Pathogenic Factor.探讨具有不同致病因素的慢性肾脏病与肠道微生物群-代谢物特征之间的相关性。
Microbiol Spectr. 2023 Feb 14;11(1):e0280522. doi: 10.1128/spectrum.02805-22. Epub 2022 Dec 8.
10
Probiotic Bifidobacteria Mitigate the Deleterious Effects of -Cresol in a Drosophila melanogaster Toxicity Model.双歧杆菌益生菌减轻黑腹果蝇毒性模型中 - 甲酚的有害影响。
mSphere. 2022 Dec 21;7(6):e0044622. doi: 10.1128/msphere.00446-22. Epub 2022 Nov 2.